From: CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
 | HR | p-value | 95% CI | n° cases | LR Chi2 | Prob > Chi2 |
---|---|---|---|---|---|---|
% CCR7 (continuous) | 1.004 | 0.235 | 0.997–1.013 | 92 | 1.52 | 0.217 |
% CCR7 (high/low) | 2.426 | 0.044 | 1.026–5.739 | 93 | 5.08 | 0.024 |
% CCR7 within the CCR7-high group (continuous) | 0.988 | 0.092 | 0.973–1.002 | 80 | 2.43 | 0.119 |